Watson Ng

2.2k total citations · 2 hit papers
29 papers, 1.6k citations indexed

About

Watson Ng is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Watson Ng has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Genetics and 8 papers in Surgery. Recurrent topics in Watson Ng's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Watson Ng is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Watson Ng collaborates with scholars based in Australia, United States and United Kingdom. Watson Ng's co-authors include Susan J. Connor, Sudarshan Paramsothy, Hazel M. Mitchell, Michael A. Kamm, Rupert W. Leong, Douglas Samuel, Thomas J. Borody, Alissa Walsh, Enmoore Lin and Johan van den Bogaerde and has published in prestigious journals such as The Lancet, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Watson Ng

26 papers receiving 1.5k citations

Hit Papers

Multidonor intensive faecal microbiota transplantation fo... 2017 2026 2020 2023 2017 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Watson Ng Australia 9 1.1k 885 445 414 390 29 1.6k
Ramesh Paramsothy Australia 9 1.3k 1.2× 1.0k 1.2× 520 1.2× 488 1.2× 463 1.2× 15 1.8k
Douglas Samuel Australia 6 1.1k 1.0× 893 1.0× 442 1.0× 408 1.0× 356 0.9× 8 1.5k
Johan van den Bogaerde United Kingdom 14 1.1k 1.0× 886 1.0× 475 1.1× 453 1.1× 399 1.0× 26 1.8k
Jess L. Kaplan United States 18 649 0.6× 688 0.8× 543 1.2× 302 0.7× 290 0.7× 43 1.8k
Vandana Midha India 24 552 0.5× 451 0.5× 1.1k 2.4× 462 1.1× 971 2.5× 136 2.2k
J. Cosnes France 6 808 0.8× 316 0.4× 339 0.8× 180 0.4× 511 1.3× 10 1.3k
Simon Mark Dahl Baunwall Denmark 15 703 0.7× 709 0.8× 923 2.1× 302 0.7× 90 0.2× 53 1.8k
H Wenzl Austria 19 378 0.4× 352 0.4× 444 1.0× 244 0.6× 438 1.1× 47 1.2k
Kristian Holm Norway 21 728 0.7× 304 0.3× 466 1.0× 105 0.3× 181 0.5× 39 1.6k
Maribeth R. Nicholson United States 14 407 0.4× 566 0.6× 342 0.8× 207 0.5× 125 0.3× 48 924

Countries citing papers authored by Watson Ng

Since Specialization
Citations

This map shows the geographic impact of Watson Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Watson Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Watson Ng more than expected).

Fields of papers citing papers by Watson Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Watson Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Watson Ng. The network helps show where Watson Ng may publish in the future.

Co-authorship network of co-authors of Watson Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Watson Ng. A scholar is included among the top collaborators of Watson Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Watson Ng. Watson Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Alison, Annabelle Lukin, Watson Ng, et al.. (2024). On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease. Patient Education and Counseling. 130. 108487–108487. 2 indexed citations
2.
McNamara, Judith, Wayne H. Wilson, Simon Ghaly, et al.. (2024). P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn s and Colitis. 18(Supplement_1). i650–i650.
4.
Lukin, Annabelle, Alison Moore, Watson Ng, et al.. (2023). Adolescents and young adults communicating with gastroenterologists: variation in inflammatory bowel disease clinical communication. International Journal of Adolescent Medicine and Health. 35(4). 347–361. 3 indexed citations
5.
Farzin, Mahtab, Andrew Gilmore, Harry Crane, et al.. (2023). Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis. ACG Case Reports Journal. 10(2). e00978–e00978. 2 indexed citations
6.
Ng, Watson, Crispin Corte, Ali Gholamrezaei, et al.. (2022). Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease. World Journal of Gastroenterology. 28(23). 2597–2608. 19 indexed citations
7.
Aston, Diana A., et al.. (2022). To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World Journal of Gastrointestinal Oncology. 14(9). 1798–1807. 1 indexed citations
8.
Li, Tracy, Warren Seow, Jana Bednarz, et al.. (2021). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. JGH Open. 5(9). 1063–1070. 5 indexed citations
10.
Wen, Amy M., Wei Xuan, Jane M. Andrews, et al.. (2021). Management Decisions in Crohn’s Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels. Crohn s & Colitis 360. 3(3). otab042–otab042. 1 indexed citations
11.
Girgis, Afaf, et al.. (2020). Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study. Journal of Medical Internet Research. 23(2). e15946–e15946. 1 indexed citations
12.
Lin, Brian L., et al.. (2019). Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings. Internal Medicine Journal. 51(5). 739–745. 14 indexed citations
13.
Paramsothy, Sudarshan, Shaun Nielsen, Michael A. Kamm, et al.. (2018). Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Gastroenterology. 156(5). 1440–1454.e2. 375 indexed citations breakdown →
14.
Paramsothy, Sudarshan, Michael A. Kamm, Nadeem O. Kaakoush, et al.. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. The Lancet. 389(10075). 1218–1228. 910 indexed citations breakdown →
15.
Connor, Susan J., et al.. (2016). Comparison of infliximab drug measurement across three commercially available ELISA kits. Pathology. 48(6). 608–612. 20 indexed citations
16.
Bye, William A., et al.. (2016). Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine. Gastroenterology. 150(4). S564–S565. 1 indexed citations
17.
Grafton, Rachel, Paul Leach, Watson Ng, et al.. (2015). P353. Are we under-recognizing skewed thiopurine metabolism in IBD patients? Routine thiopurine metabolite measurement yields clinical benefit at 12 months: A retrospective observational study.. Journal of Crohn s and Colitis. 9(suppl 1). S255–S255. 1 indexed citations
18.
Paramsothy, Sudarshan, Thomas J. Borody, Enmoore Lin, et al.. (2015). Donor Recruitment for Fecal Microbiota Transplantation. Inflammatory Bowel Diseases. 21(7). 1600–1606. 112 indexed citations
20.
Loss, Martin, Watson Ng, Rooshdiya Z. Karim, et al.. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. role of emergency liver transplantation. Liver Transplantation. 12(7). 1152–1155. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026